METHODS Articles used included randomized controlled clinical trials of adults ranging from 50 to 75 years of age who had undergone either angioplasty.

Slides:



Advertisements
Similar presentations
The value of DES in unprotected left main lesions has not been evaluated by dedicated randomized clinical trials. Especially, it is not known whether currently.
Advertisements

Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
J. Mehilli, A. Kastrati, K. Huber, S. Schulz, J. Pache, C.Markwardt, S. Kufner, F. Dotzer, K. Schlotterbeck, J. Dirschinger, A. Schömig. Abciximab in Patients.
Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly Findings From the Get With the Guidelines Quality-
METHODS A systematic review of evidence-based literature was performed using Medline and Cochrane databases. Studies reviewed include randomized controlled.
ARTS I & II Keith D Dawkins Southampton University Hospital.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Angioplasty’s Fight against Restenosis: Drug Eluting Stents & Bare Metal Stents.
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
PCI VS CABG JOURNAL REVIEW
REFERENCES 1.Roberts E, Morgan R, King D, Clerkin L. Funduscopy: a forgotten art? Postgrad Med J. 1999; 75: McComiskie JE, Greer RM, Gole GA.
METHODS Setting Kansas Study population Kansas Physician Assistants Study design Cross-sectional Measurements / Data points collected A survey consisting.
M.Unverdorben; TCT Problem The treatment of stenoses of small coronary arteries (SVD) and of restenoses after stent deployment (ISR) still show.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
Evaluation of Primary Versus Secondary Prevention of Cervical Cancer: an evidence based literature review Jennifer Vestle, PA-S, John Carter, PhD Department.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
SCAAR UCR SWEDEN 2007 Stefan James, Jörg Carlsson, Johan Lindbäck, Tage Nilsson, Ulf Stenestrand, Lars Wallentin and Bo Lagerqvist for the SCAAR study.
Coronary Stenting: Drug-eluting vs Bare-metal Natalie Cleaver, PA-S Lock Haven University PA Program Evidence Based Medicine February 26, 2009.
Elective Stenting versus Balloon Angioplasty with Bail-out Stenting for Small Vessel Coronary Artery Disease: Evidence from a Meta-analysis of Randomized.
METHODS This was an evidenced-based medicine literature review using Medline and included articles from 1998 to the present. Peer-reviewed articles were.
This material was developed by Oregon Health & Science University, funded by the Department of Health and Human Services, Office of the National Coordinator.
1 SIROLIMUS-ELUTING STENTS FOR IN-STENT RESTENOSIS TREATMENT IN 278 UNSELECTED PATIENTS: INSIGHTS ON LONG-TERM OUTCOMES FROM A LARGE TWO-CENTER REGISTRY.
Tarunjit Singh Department of Internal Medicine Westchester Medical Center New York Medical College Valhalla NY.
Disclosures The presenter has no financial involvement with the product or competing products being discussed. The presenter received travel and lodging.
METHODS This research study was completed by performing a systematic review of evidence- based literature. The following databases were used: MEDLINE FirstSearch,
Rapamycin- and Paclitaxel-Eluting Stents With Identical Biodegradable Polymeric Coating and Design Trial Presented at The American College of Cardiology.
METHODS Articles used included children and adolescents ranging in age from infancy to 18 years of age who met the Diagnostic and Statistical Manual of.
Evidence-Based Medicine – Definitions and Applications 1 Component 2 / Unit 5 Health IT Workforce Curriculum Version 1.0 /Fall 2010.
Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons Presented at The American Heart Association Scientific Session 2006 Presented by Dr.
Maurizio Menichelli MD San Camillo Hospital, Rome ( SESAMI Trial) Maurizio Menichelli Presenter Disclosure Information Nothing to Disclose Randomized trial.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
The Role of Secondary Versus Tertiary Prevention in Decreasing the Incidence of Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus Lindsay.
Dissolvable Heart Stents Richard Melpignano. Coronary Heart Disease Coronary Heart Disease (CHD) is, as of 2012, the leading cause of death worldwide.
Two-Year Outcomes After Everolimus- or Sirolimus- Eluting Stents in Patients With Coronary Artery Disease in the ISAR-TEST 4 Trial Robert A. Byrne, Adnan.
Need Statement and Need Criteria. Need Statement To prevent the reoccurrence of stenosis in coronary arteries. More specifically, to create a solution.
Heterogeneity and Comparative Effectiveness: Implications for Studies, Reviews, and Policy David Atkins, MD, MPH Health Services Research and Development.
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.
RESOLUTE US One-Year Clinical Outcomes from the Pivotal Multicenter RESOLUTE US Study Objective To evaluate the clinical effectiveness of the Resolute.
PRACTICAL RECOMMENDATIONS ON ANTI- THROMBOTIC TREATMENT IN PATIENTS TREATED WITH DRUG-ELUTING STENTS Giuseppe Biondi-Zoccai Ospedale S. Giovanni Battista.
Prospective, Randomized Trial of Paclitaxel-Eluting Balloon versus Paclitaxel-Eluting Stent versus Balloon Angioplasty for Treatment of Coronary Restenosis.
? What more will it take to turn the tide of treatment for angina patients from a PCI-first to an optimal medical therapy– first approach? 1.
Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Evidence-Based Medicine: A Basic Primer Kevin Bradford, M.L.S. Clinical Information Librarian Instructor Medical College of Georgia April 2007.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: A comparison of three-year survival after coronary.
Efficacy of Colchicine When Added to Traditional Anti- Inflammatory Therapy in the Treatment of Pericarditis Efficacy of Colchicine When Added to Traditional.
The GREAT Trial. The Grampian Region Early Anistreplase Trial Reference Zahringer M, Sapoval M, Pattynama PM, et al. Sirolimus-eluting versus bare-metal.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantation of a Drug-Eluting Stent With a Different.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization.
Results From the MISSION! Intervention Study Sirolimus-Eluting Stents Vs Bare-Metal Stents in Patients With STEMI : 9-Month Angiographic and Intravascular.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Are the Culprit Lesions Severely Stenotic? J Am Coll.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at The American College.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Revascularization of the Heart
From: Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med.
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
Stenting of Coronary Arteries in Non Stress/Benestent Disease
Catheter-Based Treatment of Coronary Artery Disease
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Peter K. Smith, MD  The Journal of Thoracic and Cardiovascular Surgery 
Peter K. Smith, MD  The Annals of Thoracic Surgery 
The American College of Cardiology Presented by Dr. Raimund Erbel
Figure 1 Milestones in coronary angioplasty
Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease  Robert.
Maintenance of Long-Term Clinical Benefit with
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial
Coronary Revascularization on Balance: Robert L. Frye Lecture
P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.
Presentation transcript:

METHODS Articles used included randomized controlled clinical trials of adults ranging from 50 to 75 years of age who had undergone either angioplasty or stenting from the years 1979 to 2006.Articles used included randomized controlled clinical trials of adults ranging from 50 to 75 years of age who had undergone either angioplasty or stenting from the years 1979 to Key variables evaluated through the Medline database included angioplasty, stenting, and drug-eluting stents.Key variables evaluated through the Medline database included angioplasty, stenting, and drug-eluting stents. CONCLUSIONS After evaluation of the current research concerning the interventional treatment of CAD, the conclusion exists that PTCA with stenting is more efficacious than PTCA alone, yet no conclusion may be made concerning if drug-eluting stenting is more efficacious than bare-metal stenting due to safety concerns seldom seen with bare- metal stents. After evaluating the evidence in the literature, the overall grade of evidence for this project was a B. The best and safest treatment for patients with CAD is PTCA with stenting with insufficient evidence to conclude which stent type is more efficacious. [3] REFERENCES 1. Mehran R, Dangas G, Abizaid A, Lansky A, Mintz G, Pichard A, Satler L, Kent K, Waksman R, Stone G, Leon M. Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results. The American Heart Journal April: 141: Lagervist B, James S, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term Outcomes with Drug-eluting Stents versus Bare-metal Stents in Sweden. NEJM. 2007: 356: Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli Sabate M, Suttorp M, Baumgart D, Seyfarth M, Pfisterer M, Schomig A. Analysis of 14 Trials Comparing Sirolimus- Eluting Stents with Bare-metal Stents. NEJM. 2007: 356: Sackett D, Straus S, Richardson W, Rosenberg W, Haynes (2000). How to Practice and Teach EBM. Evidence-Based Medicine. Clinical Evaluation of Angioplasty Versus Stenting and Bare-Metal Stenting Versus Drug-eluting Stenting in the Treatment of Coronary Artery Disease Andrew Rendoff, PA-S, Richard D. Muma, PhD, MPH, PA-C Department of Physician Assistant College of Health Professions, Wichita, Kansas INTRODUCTION This study focused on the efficacy of angioplasty and stenting in the treatment of coronary artery disease (CAD).This study focused on the efficacy of angioplasty and stenting in the treatment of coronary artery disease (CAD). Over the past twenty-five years, the concepts of percutaneous transluminal coronary angioplasty (PTCA) and stenting have become dominant modalities in the treatment of CAD.Over the past twenty-five years, the concepts of percutaneous transluminal coronary angioplasty (PTCA) and stenting have become dominant modalities in the treatment of CAD. In the late 1970’s and early 1980’s, PTCA was seen as the best possible alternative to bypass surgery until repetitive treatments were required to reopen occluded arteries. [1] Following the failure of PTCA, stenting and derivatives of stenting with drug-eluting compounds have been developed to examine the most effective revascularization technique to reduce the rate of coronary re- stenosis.In the late 1970’s and early 1980’s, PTCA was seen as the best possible alternative to bypass surgery until repetitive treatments were required to reopen occluded arteries. [1] Following the failure of PTCA, stenting and derivatives of stenting with drug-eluting compounds have been developed to examine the most effective revascularization technique to reduce the rate of coronary re- stenosis. The purpose of this study was to perform a systematic examination of the literature to evaluate these techniques and determine the most effective treatment for patients with CAD.The purpose of this study was to perform a systematic examination of the literature to evaluate these techniques and determine the most effective treatment for patients with CAD. RESULTS Thirty-seven articles met the inclusion criteria and were reviewed for accuracy and applicability.Thirty-seven articles met the inclusion criteria and were reviewed for accuracy and applicability. Analysis of the included articles revealed an abundance of information supporting the efficacy of PTCA with stenting, but insufficient evidence to conclude whether drug-eluting stenting is more effective than bare-metal stenting (Figure 1). DISCUSSION While the current literature available to medical practitioners is quite extensive, there is yet to be a distinct answer to the treatment of choice for patients with CAD.While the current literature available to medical practitioners is quite extensive, there is yet to be a distinct answer to the treatment of choice for patients with CAD. From this study, the clinical application of interventional stenting is recommended versus angioplasty alone. [1]From this study, the clinical application of interventional stenting is recommended versus angioplasty alone. [1] Additionally, while drug-eluting stents may be more effective in reducing re-stenosis and the subsequent need for re-intervention, safety concerns (i.e. increased risk of stent thrombosis, aneurysm, and further myocardial infarction) prevent the researchers to conclude whether drug-eluting or bare-metal stents are more effective in treating CAD. [2-3]Additionally, while drug-eluting stents may be more effective in reducing re-stenosis and the subsequent need for re-intervention, safety concerns (i.e. increased risk of stent thrombosis, aneurysm, and further myocardial infarction) prevent the researchers to conclude whether drug-eluting or bare-metal stents are more effective in treating CAD. [2-3] Percentages of each technique supported by current research is visible is Figure 2.Percentages of each technique supported by current research is visible is Figure 2. Evaluation of the articles revealed: 51.4% of the articles were level 1, 13.5% level 2, and 35.1% were level 3Evaluation of the articles revealed: 51.4% of the articles were level 1, 13.5% level 2, and 35.1% were level 3. Overall grade of recommendation from the evidence was aOverall grade of recommendation from the evidence was a B. [4] Figure 1 Figure 2. Results (Percent) 37 total articles, one paper addresses more than one topic.